(Q33954673)

30 July 2017

title

In vitro antibiotic resistance in bacterial keratitis in London (English)

1 reference

30 July 2017

main subject

antibiotic resistance

1 reference

Tuft SJ

1

1 reference

30 July 2017

Matheson M

series ordinal

2

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 July 2000

1 reference

30 July 2017

number of pages

5

1 reference

British Journal of Ophthalmology

inferred from page(s)

published in

1 reference

30 July 2017

volume

84

1 reference

30 July 2017

issue

7

1 reference

30 July 2017

page(s)

687-691

1 reference

Ciprofloxacin-resistant Pseudomonas keratitis.

30 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1723533

Emerging fluoroquinolone resistance in bacterial keratitis: a 5-year review

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1723533

Lack of evidence for systemic toxicity following topical chloramphenicol use.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1723533

Topical 0.3% ciprofloxacin, norfloxacin, and ofloxacin in treatment of bacterial keratitis: a new method for comparative evaluation of ocular drug penetration

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1723533

Ciprofloxacin, a quinolone carboxylic acid compound active against aerobic and anaerobic bacteria

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1723533

Mechanism of ciprofloxacin resistance in Pseudomonas aeruginosa.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1723533

Mechanisms of action of and resistance to ciprofloxacin

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1723533

Clinical pharmacokinetics of ciprofloxacin

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1723533

Increasing resistance of Staphylococcus aureus to ciprofloxacin

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1723533

Emergent resistance to ciprofloxacin amongst Pseudomonas aeruginosa and Staphylococcus aureus: clinical significance and therapeutic approaches

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1723533

Ciprofloxacin-resistant methicillin-resistant Staphylococcus aureus in an acute-care hospital

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1723533

Microbiologic aspects of fluoroquinolones

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1723533

Ciprofloxacin-resistant bacterial keratitis.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1723533

Initial therapy of suspected microbial corneal ulcers. II. Specific antibiotic therapy based on corneal smears

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1723533

Initial therapy of suspected microbial corneal ulcers. I. Broad antibiotic therapy based on prevalence of organisms

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1723533

In vitro susceptibility of bacterial keratitis pathogens to ciprofloxacin. Emerging resistance.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1723533

Fluoroquinolones in the treatment of bacterial keratitis

29 October 2018

1 reference

12 December 2020

Differential care of corneal ulcers in the community based on apparent severity

1 reference

12 December 2020

Comparison of ciprofloxacin ophthalmic solution 0.3% to fortified tobramycin-cefazolin in treating bacterial corneal ulcers. Ciprofloxacin Bacterial Keratitis Study Group

1 reference

12 December 2020

Ofloxacin monotherapy for the primary treatment of microbial keratitis: a double-masked, randomized, controlled trial with conventional dual therapy. The Ofloxacin Study Group

1 reference

12 December 2020

Topical vs subconjunctival treatment of bacterial corneal ulcers

1 reference

12 December 2020

The effect of concentrated antibiotics on the rabbit's corneal epithelium

1 reference

12 December 2020

Ciprofloxacin-resistant Staphylococcus aureus

1 reference

12 December 2020

1 reference

12 December 2020

An in vitro study of the potency and stability of fortified ophthalmic antibiotic preparations

1 reference

12 December 2020

Conjunctival necrosis after administration of topical fortified aminoglycosides

1 reference

12 December 2020

Corneal stromal penetration of topical ciprofloxacin in humans

1 reference

12 December 2020

Ciprofloxacin-resistant bacterial keratitis

1 reference

12 December 2020

0.3% ciprofloxacin ophthalmic ointment in the treatment of bacterial keratitis. The Ciprofloxacin Ointment/Bacterial Keratitis Study Group

1 reference

12 December 2020

Corneal tissue levels of topically applied ciprofloxacin

1 reference

12 December 2020

Efficacy of ofloxacin vs cefazolin and tobramycin in the therapy for bacterial keratitis. Report from the Bacterial Keratitis Study Research Group

1 reference

12 December 2020

Susceptibility of corneal and conjunctival pathogens to ciprofloxacin

1 reference

12 December 2020

Identifiers

DOI

10.1136/BJO.84.7.687

1 reference

30 July 2017

1 reference

30 July 2017

1 reference